debt
confidence high
sentiment positive
materiality 0.60
Lifecore extends BMO revolving credit facility to Nov 2027, lowers rates
LIFECORE BIOMEDICAL, INC. DE
- Maturity extended three years to November 2027 under BMO ABL facility.
- Interest rates simplified and reduced; no fees paid for amendments.
- Alcon term loan covenants aligned with BMO facility via separate amendment.
- Follows $24.3M PIPE financing; company says balance sheet strengthened.
- CEO cites BMO confidence and recent customer wins including Lindy Biosciences.